Literature DB >> 7875653

Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia.

F J Paula1, L M Gouveia, G M Paccola, C E Piccinato, A C Moreira, M C Foss.   

Abstract

The study was designed to investigate the influence of androgens on peripheral glucose metabolism in women with congenital adrenal hyperplasia (CAH). Nine normal women and seven women with CAH were studied (4 with the classical form of 21-hydroxylase deficiency [C 21-OH] and 3 with nonclassical 21-hydroxylase deficiency [NC 21-OH]). The study was performed using the forearm model combined with local indirect calorimetry. The insulin level reached 30 minutes after glucose ingestion was significantly greater (p < .05) in patients with CAH. The patients with C 21-OH had elevated androstenedione (A) and testosterone (T) and low DHEA-S and presented a 35% greater insulin response to a glucose stimulus than the control group, area under the curve (AUC) of 9457 +/- 887 vs 6989 +/- 833 microU/ml.3 hours. Patients with NC 21-OH had slightly elevated T, A and DHEA-S and presented an insulin response that was similar to the control group, AUC = 7208 +/- 1935 microU/ml.3 hours. Despite the greater muscle mass of the patients with CAH the forearm glucose uptake during the three hours of the study was lower in these patients than in normal women (CAH = 100.9 +/- 10.0 vs control group = 132.5 +/- 21.2 mg/100 ml forearm). The ratio of insulin response to the increment of forearm glucose uptake over a period of 3 h was significantly higher in patients with CAH (control group = 59.6 +/- 6.5 vs CAH = 98.6 +/- 19.4 microU.ml-1/mg.100 ml forearm-1, p < 0.05). These results suggest that insulin sensitivity is decreased in patients with CAH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7875653     DOI: 10.1055/s-2007-1001755

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiency.

Authors:  Hui-Jie Zhang; Jun Yang; Man-Na Zhang; Chang-Qin Liu; Min Xu; Xue-Jun Li; Shu-Yu Yang; Xiao-Ying Li
Journal:  Endocrine       Date:  2010-10-27       Impact factor: 3.633

2.  Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia.

Authors:  N H Amr; A Y Ahmed; Y A Ibrahim
Journal:  J Endocrinol Invest       Date:  2014-08-12       Impact factor: 4.256

Review 3.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

Review 4.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

5.  Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia.

Authors:  Amy Fleischman; Harriet Paltiel; Jeanne Chow; Julie Ringelheim; Catherine M Gordon
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-04       Impact factor: 1.814

6.  Identification of new biomarker candidates for glucocorticoid induced insulin resistance using literature mining.

Authors:  Wilco Wm Fleuren; Erik Jm Toonen; Stefan Verhoeven; Raoul Frijters; Tim Hulsen; Ton Rullmann; René van Schaik; Jacob de Vlieg; Wynand Alkema
Journal:  BioData Min       Date:  2013-02-04       Impact factor: 2.522

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.